Publication | Closed Access

Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53

Cancer ImmunosurveillanceMedicineImmunologyImmunoeditingPathologyImmune Checkpoint InhibitorImmune RecognitionCyclin B1Tumor SuppressorTumor AntigenImmunotherapyOncologyCancer ResearchTumor MicroenvironmentTumor Biology